Colorectal cancer (CRC) accounts for 9% of all new cancer cases worldwide and affects
over 1 million people each year. Screening can reduce the mortality associated with the …

Colorectal cancer (CRC) is a major health problem worldwide. Although population‐based
CRC screening is strongly recommended in average‐risk population, compliance rates are …

Objective This study aimed to evaluate how the knowledge and perception towards
colorectal cancer (CRC) screening had been changed in a large population, and identified …

Screening reduces the incidence, morbidity, and mortality of colorectal cancer, yet
participation tends to be low. We undertook a systematic review and meta-study synthesis of …

Screening reduces colorectal cancer mortality; however, this remains the second leading
cause of cancer deaths in the United States and adherence to colorectal cancer screening …

Randomized controlled trials (RCT) have shown the efficacy of screening for colorectal
cancer (CRC) using the fecal occult blood test (FOBT) and follow-up with colonoscopy. We …

Background There is controversy regarding how comorbidity impacts on colorectal cancer
screening, especially in the context of organised programmes. The aim of this study is to …

Objectives Colorectal cancer (CRC) is the third most common cancer. Many countries in
Europe have already implemented systematic screening programmes as per the …

Colorectal cancer ranks as one of the most incidental and death malignancies worldwide.
Colorectal cancer screening has proven its benefit in terms of incidence and mortality …

Objective Participation, an indicator of screening programme acceptance and effectiveness,
varies widely in clinical trials and population-based colorectal cancer (CRC) screening …